Stephen Tobin

Paul Maher serves as a Vice Chair of Greenberg Traurig. He concentrates on corporate law, particularly cross-border public and private mergers and acquisitions. He advises a wide range of domestic and international clients in numerous sectors, including chemicals, pharmaceuticals, life sciences, financial services, information services, retail and communications. Paul is highly recommended by both of the leading independent guides to the legal industry. In its 2020 edition, Chambers UK stated...

Carolyn Jackson helps clients solve complex cross-border issues involving the regulation of financial institutions and financial products, including derivatives. Carolyn's depth of knowledge and practical approach are shaped by her first-hand experience: she managed the New York trading desk of several investment banks and was formerly the executive director of the International Swaps and Derivatives Association, Inc. Trading firms, banks, asset managers, clearing houses and trading venues re...

Anthony Maton has more than 25 years' experience of litigating claims in the UK, Europe and across the globe. In 2009, Anthony co-founded Hausfeld & Co LLP in London which he led as Managing Partner until 2021. He was appointed Global Co-Chair in January 2022.

Simon Airey focuses his practice on global, cross-border and internal investigations, financial and regulatory crime, bribery and corruption, money laundering, tax and fraud inquiries, data breaches, dawn raids, asset tracing, international enforcement and corporate compliance issues. He has conducted a wide range of investigations and corporate defence assignments in different sectors, including construction, defence, financial services, gambling, oil and gas, logistics, pharmaceuticals and ...

Clients value the support, guidance, and leadership that Phillip Taylor brings to a situation and his technical and commercial approach to delivering innovative solutions to the most complex issues involving international restructuring, special situations, and insolvency. He represents companies, creditors, and investors in all parts of the capital structure, as well as corporate trustees, agents, directors, and insolvency practitioners. Phillip routinely handles both contentious and non-cont...

Malcolm Bates is a partner in Goodwin’s Technology and Life Sciences groups based in Cambridge and London. He specialises in the commercialisation of intellectual property rights with particular expertise in life sciences. Mr. Bates advises on transactions, including licences, collaborations, distribution, manufacturing, outsourcing and R&D projects, as well as regulatory matters, contract and patent disputes, fundraisings, M&A transactions and IPOsPrior to joining Goodwin, he w...

Andrew Savage focuses his practice on international commercial and finance litigation and international arbitration. Over a period of more than 25 years he has a gained a wealth of experience across all sectors and industries, including finance, insolvency, energy, insurance (for policy holders), commodities, shipping, construction, IT and art theft. Much of his casework has involved dealing with issues of fraud and corruption and the need for global asset tracing and international enforcement.

Paul Fleming is a top attorney recognized by Best Lawyers in the practice area(s) of Insolvency and Restructuring Law. Paul, who practices law in London, United Kingdom, has been recognized since 2021. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Paul is held by other top lawyers in the same geographic and legal practice area.

Joel D. Harrison is a top attorney recognized by Best Lawyers in the practice area(s) of Information Technology Law and Outsourcing. Joel D., who practices law in London, United Kingdom, has been recognized since 2022. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Joel D. is held by other top lawyers in the same geographic and legal practice area.

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...